Abstract:Background Chronic kidney disease is common in heart failure with preserved ejection fraction (HFpEF). However, the biologic correlates and the prognostic significance of kidney injury (KI), above and beyond estimated glomerular filtration rate (eGFR) are not well understood. We evaluated the proteomic correlates and prognostic significance of KI assessed with a combination of plasma protein biomarkers in HFpEF. Methods Using baseline frozen plasma samples from the TOPCAT trial, we measured the following KI biomarkers using an aptamer-based assay (SomaScan®): cystatin-C (CST-C), fatty acid-binding protein-3 (FABP3), Beta-2 microglobulin (B2M), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM1). Factor analysis was used to extract the common variability underlying these biomarkers. We assessed the relationship between the KI factor score and the composite of death and heart failure hospital admission (DHFA). We used linear regression to assess the relationship between KI factor score and ∼5,000 plasma proteins, followed by pathway analysis, to assess proteomic correlates of KI. HFpEF participants enrolled in the Penn heart failure study (PHFS) were used as a validation cohort. Results A single underlying KI factor underlying the variability of KI biomarkers was found. KI factor score was associated with diabetes, higher meta‐analysis global group in chronic HF (MAGGIC) risk scores, higher N-terminal B-type natriuretic peptide levels, lower estimated glomerular filtration rate (eGFR) and lower diastolic blood pressure. In Cox models (Figure) adjusted for the MAGGIC risk score and eGFR, KI was significantly and independently associated with the risk of DHFA (Standardized hazard ratio=1.98; 95%CI=1.1.59-2.47; P<0.0001). KI was predominantly associated to proteins and biologic pathways related to inflammation, complement activation, cholesterol homeostasis and fibrosis. KI was associated with 140 proteins which reproduced across cohorts after correction for multiple comparisons. Findings regarding clinical correlates, biologic associations, and prognostic significance of KI were also reproduced in the validation cohort. Conclusion KI, assessed with a combination of plasma proteins, is associated with adverse outcomes in HFpEF. This relationship is independent of baseline eGFR, suggesting that ongoing KI is related to adverse outcomes. Patients with HFpEF and ongoing KI exhibit a plasma proteomic signature indicative of inflammation, complement activation, fibrosis, and impaired cholesterol homeostasis.

Fatty acid‐binding protein‐3 and renal function decline in patients with chronic coronary syndrome

Urine liver fatty acid binding protein and chronic kidney disease progression

Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients

Associations between High Serum Adipocyte Fatty Acid Binding Protein and First Hospitalization in Kidney Transplantation Patients: A 5-Year Follow-up Study

Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure

Serum Levels Of Adipocyte Fatty Acid-Binding Protein Are Associated With The Severity Of Coronary Artery Disease In Chinese Women

Elevated serum fatty acid-binding protein 4 level predicts all-cause and cardiovascular mortality in peritoneal dialysis patients: a five-year study

Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention

Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure

FABP1 and FABP2 as markers of diabetic nephropathy

Pathophysiological role of fatty acid-binding protein 4 in Asian patients with heart failure and preserved ejection fraction

Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.

Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study

High-expression of FABP4 in Tubules is a Risk Factor for Poor Prognosis in DKD Patients.

Value of urinary liver-type fatty acid binding protein in prediction of renal function progression in patients with chronic glomerulonephritis

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Association of Serum Adipocyte Fatty Acid Binding Proteins with Coronary Artery Disease and Its Risk Factors

Prognostic Value of Serum Concentration of Heart-Type Fatty Acid-Binding Protein on Acute Coronary Syndrome at Early Stage

Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D.

Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort

Proteomic Correlates And Prognostic Significance Of Kidney Injury In Heart Failure With Preserved Ejection Fraction